Professor, Medicine, Pennsylvania State University College of Medicine
Gastroenterology
Dr. Jill P. Smith, MD
|
|
Give Review
Jill Smith works in the field of Gastroenterology. He attended University of Florida College of Medicine. University of Florida College of Medicine has a rank of 43 in research and a 78 in primary care Jill Smith is a published doctor. He has 19 publications published. The most current publication "Distribution of Cholecystokinin-B Receptor Genotype Between Patients With Pancreatic Cancer and Controls and Its Impact on Survival." He accepts all Medicare patients.
Publications
- Distribution of Cholecystokinin-B Receptor Genotype Between Patients With Pancreatic Cancer and Controls and Its Impact on Survival.
- Novel strategies for managing pancreatic Cancer.
- Cholecystokinin Mediates Progression and Metastasis of Pancreatic Cancer Associated with Dietary Fat.
- PhotoImmunoNanoTherapy Reveals an AntiCancer Role for Sphingosine Kinase 2 and Dihydrosphingosine-1-Phosphate.
- Safety and Tolerability of Low-dose Naltrexone Therapy in Children With Moderate to Severe Crohn's Disease: A Pilot Study.
- Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis.
- Calcium phosphosilicate nanoparticles for imaging and photodynamic therapy of Cancer.
- Down-regulation of the CCK-B Receptor in Pancreatic Cancer Cells Blocks Proliferation and Promotes Apoptosis.
- Therapy with the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn's Disease: A Randomized Placebo-Controlled Trial.
- Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic Cancers in vivo.
- Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic Cancer.
- Growth of human pancreatic Cancer is inhibited by down-regulation of gastrin gene expression.
- The opioid antagonist naltrexone improves murine inflammatory bowel Disease.
- Low-dose naltrexone therapy improves active Crohn's Disease.
- The functional significance of the cholecystokinin-C (CCK-C) receptor in human pancreatic Cancer.
- Amantadine therapy for chronic Hepatitis C.
- Amantadine therapy for chronic Hepatitis C: a dose escalation study.
- Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients.
Schools
University Of Florida College Of Medicine
Procedures Preformed
- Colon Cancer Screening
- Colonoscopy With Polypectomy
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Capital Blue Cross
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access
- Commercial Insurance Company
- CoreSource
- Group Plan PPO
- Gateway Health Plan
- Harvard Pilgrim Health Care PPO
- Highmark Blue Cross Blue Shield
- Humana
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- TriCare for Life
- Choice Plus POS
- Options PPO
- United Healthcare
- Universal American
- UPMC Health Plan
Education
-
University of Missouri-Columbia -
University of Florida College of Medicine
Hospital
-
Penn State Milton S. Hershey Medical Center
Helpful Reviews
Similar Doctors
|
|
Tracy J. Edwards, FNP
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sabeen F. Medvedev, MD |
|
|
Dr. Chareon Mankongpaisamrung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nidhi Malhotra, MD |
|
|
Dr. Divyanshoo R. Kohli, MD |
|
|
Dr. Shervin Shafa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Junette C. Gibbons, MD |
|
|
Dr. James Lewis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zone-En Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Asghar Shaigany, MD
This Doctor is OpenDoctor Recommended.
|